Although many approaches have been tested to overcome the insulin dependence caused by the pancreatic β-cells destruction observed in individuals affected by type 1 diabetes (T1D), medical research has largely failed to halt the onset or to reverse T1D.
Immunotherapy for type 1 diabetes / D. Frumento, M.B. Nasr, B.E. Essawy, F. D'Addio, G.V. Zuccotti, P. Fiorina. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - (2017 Mar 04). [Epub ahead of print] [10.1007/s40618-017-0641-y]
Immunotherapy for type 1 diabetes
M.B. Nasr;F. D'Addio;G.V. ZuccottiPenultimo
;P. Fiorina
Ultimo
2017
Abstract
Although many approaches have been tested to overcome the insulin dependence caused by the pancreatic β-cells destruction observed in individuals affected by type 1 diabetes (T1D), medical research has largely failed to halt the onset or to reverse T1D.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
art_10.1007_s40618-017-0641-y.pdf
accesso riservato
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
536.71 kB
Formato
Adobe PDF
|
536.71 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
